Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Panagiotis I, Georgianos"'
Autor:
Panagiotis I Georgianos, Rajiv Agarwal
Publikováno v:
Počki, Vol 12, Iss 3, Pp 126-127 (2023)
No abstract
Externí odkaz:
https://doaj.org/article/c0b4906c8979430ea350c41f7ee5eec4
Autor:
Ioannis Kontogiorgos, Panagiotis I. Georgianos, Vasilios Vaios, Georgia Vareta, Eleni Georgianou, Apostolos Karligkiotis, Vasiliki Sgouropoulou, Konstantia Kantartzi, Pantelis E. Zebekakis, Vassilios Liakopoulos
Publikováno v:
Life, Vol 13, Iss 5, p 1140 (2023)
Prior studies have shown that among patients with chronic kidney disease not yet on dialysis, the faster progression of kidney injury in men than in women is, at least partly, explained by sex differences in ambulatory blood pressure (BP) control. Th
Externí odkaz:
https://doaj.org/article/c69a3140a8684665abde5acfefbb707a
Publikováno v:
Kidney Medicine, Vol 4, Iss 5, Pp 100468- (2022)
Externí odkaz:
https://doaj.org/article/1cd940445906482087594c2d35ce16ee
Autor:
Vassilios Liakopoulos, Panagiotis I. Georgianos, Vasilios Vaios, Stefanos Roumeliotis, Apostolos Karligkiotis, Pantelis E. Zebekakis
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-6 (2020)
Abstract Background Encapsulating-peritoneal-sclerosis (EPS) is a rare, but serious and life-threatening complication of peritoneal dialysis (PD). Treatment of EPS consists of discontinuation of PD and maintenance of nutritional status, whereas the r
Externí odkaz:
https://doaj.org/article/fddae8f76e8a4d2da91f3b1e9896bf4a
Autor:
Stefanos Roumeliotis, Athanasios Roumeliotis, Panagiotis I Georgianos, Elias Thodis, Leon J Schurgers, Katarzyna Maresz, Theodoros Eleftheriadis, Evangelia Dounousi, Giovanni Tripepi, Francesca Mallamaci, Vassilios Liakopoulos
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273102 (2022)
Vascular calcification (VC) is an active process, resulting from the disturbance of balance between inhibitors and promoters of calcification, in favor of the latter. Matrix Gla Protein, a powerful inhibitor of VC, needs vitamin K to become active. I
Externí odkaz:
https://doaj.org/article/6bb430a7fcd44e97b390308af55b5cc5
Autor:
Panagiotis I. Georgianos, Vasilios Vaios, Vasiliki Sgouropoulou, Theodoros Eleftheriadis, Dimitrios G. Tsalikakis, Vassilios Liakopoulos
Publikováno v:
Diagnostics, Vol 12, Iss 12, p 2961 (2022)
Whereas hypertension is an established cardiovascular risk factor in the general population, the contribution of increased blood pressure (BP) to the huge burden of cardiovascular morbidity and mortality in patients receiving dialysis continues to be
Externí odkaz:
https://doaj.org/article/9b9f9ae864504b76a47aadc4079518a9
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-4
Autor:
Vassilios Liakopoulos, Panagiotis I Georgianos, Paraskevi Demirtzi, Vasilios Vaios, Theofanis Kalathas, Pantelis E Zebekakis
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-4 (2018)
Abstract Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients. Although the safety and efficacy of icodextrin i
Externí odkaz:
https://doaj.org/article/dfc9257b7c8b442d807fae5c92d48283
Publikováno v:
Brazilian Journal of Nephrology, Vol 41, Iss 4, Pp 445-447 (2019)
Externí odkaz:
https://doaj.org/article/44a89488a8944975a4d57c84e2cb090f
Autor:
Panagiotis I Georgianos, Rajiv Agarwal
Publikováno v:
American Journal of Hypertension. 36:135-143
Steroidal mineralocorticoid-receptor-antagonists (MRAs), such as spironolactone and eplerenone, are guideline-directed therapies in patients with heart failure with reduced ejection fraction or resistant hypertension. However, the associated risk of